Publications, Patents, Books and Book Chapters


2017


Goldmann, D, Zdrazil, B, Digles, D & Ecker, GF 2017, 'Empowering pharmacoinformatics by linked life science data', Journal of Computer-Aided Molecular Design, vol. 31, no. 3, pp. 319-328. https://doi.org/10.1007/s10822-016-9990-4

Wellendorph, P, Jacobsen, J, Skovgaard-Petersen, J, Jurik, A, Vogensen, SB, Ecker, G, Schousboe, A, Krogsgaard-Larsen, P & Clausen, RP 2017, γ-Aminobutyric Acid and Glycine Neurotransmitter Transporters. in Transporters as Drug Targets. Wiley, pp. 69-106. https://doi.org/10.1002/9783527679430.ch4

Montanari, F, Cseke, A, Wlcek, K & Ecker, G 2017, 'Virtual Screening of DrugBank Reveals Two Drugs as New BCRP Inhibitors', Journal of Biomolecular Screening, vol. 22, no. 1, pp. 86-93. https://doi.org/10.1177/1087057116657513

2016


Puthenkalam, R, Hieckel, M, Simeone, X, Suwattanasophon, C, Feldbauer, RV, Ecker, GF & Ernst, M 2016, 'Structural Studies of GABAA Receptor Binding Sites: Which Experimental Structure Tells us What?', Frontiers in molecular neuroscience, vol. 9, 44, pp. 44. https://doi.org/10.3389/fnmol.2016.00044

Sase, A, Aher, YD, Saroja, SR, Ganesan, MK, Sase, S, Holy, M, Höger, H, Bakulev, V, Ecker, GF, Langer, T, Sitte, HH, Leban, J & Lubec, G 2016, 'A heterocyclic compound CE-103 inhibits dopamine reuptake and modulates dopamine transporter and dopamine D1-D3 containing receptor complexes', Neuropharmacology, vol. 102, pp. 186-196. https://doi.org/10.1016/j.neuropharm.2015.07.039

Schwarz, T, Montanari, F, Cseke, A, Wlcek, K, Visvader, L, Palme, S, Chiba, P, Kuchler, K, Urban, E & Ecker, G 2016, 'Subtle Structural Differences Trigger Inhibitory Activity of Propafenone Analogues at the Two Polyspecific ABC Transporters: P-Glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP)', ChemMedChem: chemistry enabling drug discovery, vol. 11, no. 12, pp. 1380-1394. https://doi.org/10.1002/cmdc.201500592